Medical Equipment & Supplies

EPA is an &omega-3 fatty acid abundantly available in marine organisms. (&plusmn)17(18)-DiHETE is one of the major metabolites produced when EPA is incubated with various rat tissue homogenates or cynomolgus monkey seminal vesicles.

A derivative of EPA derived via epoxidation of the 17,18-double bond of EPA a potent and selective activator of BK-type calcium-activated potassium ion channels in vascular smooth muscle cells.

A derivative of EPA derived via epoxidation of the 17,18-double bond of EPA a potent and selective activator of BK-type calcium-activated potassium ion channels in vascular smooth muscle cells.

(&plusmn)17-HDHA is an autoxidation product of DHA in vitro. It is also produced from incubations of DHA in rat liver, brain, and intestinal microsomes.

(&plusmn)19(20)-DiHDPA is one of the major metabolites produced when DHA is incubated with NADPH-supplemented rat liver microsomes formed by the slow metabolism of DHA by monkey seminal vesicles.

A DHA (Item No. 90310) metabolite, derived via epoxidation of the &omega-3 double bond of DHA epoxygenase metabolites of DHA have been detected in a mouse model of inflammation.

A metabolite of the CYP2C19 substrate mephenytoin that has been used for developing UPLC- MS/MS assays for evaluating CYP probe drugs and their relevant metabolites in human urine or plasma samples.

Racemic version of a CYP450 and epoxide hydrolase metabolite of arachidonic acid.

A possible metabolite produced from EPA following epoxidation of the &alpha-5 double bond.

Racemic version of a CYP450 metabolite of arachidonic acid.

(&plusmn)5-HEPE is produced by non-enzymatic oxidation of EPA. It contains equal amounts of 5(S)-HEPE and 5(R)-HEPE.

(&plusmn)5-HEPE is produced by non-enzymatic oxidation of EPA. It contains equal amounts of 5(S)-HEPE and 5(R)-HEPE.